Evidence-based insights into peptide protocols, safety research, and optimization strategies. Built on clinical rigor, powered by community knowledge.
Get weekly insights on peptide protocols, safety updates, and optimization strategies delivered to your inbox.
No spam. Unsubscribe anytime. Clinical rigor, always.
Comprehensive outcome research with safety data and practical protocol references
Cardiac peptide therapy isn't science fiction — Tβ4 has completed Phase 2 in acute MI (NCT05984134), and SS-31 sits in advanced-phase trials for mitochondrial heart disease.
A plain-English look at the peptides being investigated for cardiovascular repair — Thymosin β4 for post-infarct tissue regeneration, elamipretide for mitochondrial membrane stability, and the adjacent vascular-bioregulator layer.
Detailed compound profiles with mechanisms, safety data, and dosing protocols
Evidence-based supplement stacks designed to support your peptide protocols
Inflammation isn't just something to suppress — peptides like ARA-290 and KPV suggest you can reprogram the response entirely.
A plain-English look at the peptides being investigated for inflammation and tissue repair — what the evidence shows, what's still missing, and where the safety line sits.
Sleep is not a pause — it is the most active regenerative state your biology runs. The peptides here tune its architecture without sedating the system.
Most sleep aids work by suppressing the central nervous system. A small class of peptides — DSIP, Epitalon, and the CJC-1295 / Ipamorelin stack — take the opposite approach: they restore the body's own sleep rhythms, hormonal pulses, and cellular repair cycles. This is sleep as biological fine-tuning, not sedation.
The gland behind your breastbone has been shrinking since puberty — and taking your immune system with it.
Thymic involution is the progressive shrinkage of the thymus gland that accelerates immune aging. Thymic peptides like Thymosin β4 and Thymalin offer a regenerative approach to reversing this decline, with applications spanning cardiac repair, immune reconstitution, and even hair regrowth.
Our DNA is not a static blueprint of decline but a dynamic epigenetic landscape that can be re-tuned through precise molecular signaling.
Aging is a profound loss of transcriptional access, not just mechanical wear. Mitochondrial peptides like MOTS-c and SS-31, alongside epigenetic bioregulators such as Epitalon and Livagen, are rewriting the longevity playbook by restoring chromatin architecture and stabilizing the mitochondrial membrane. This protocol maps the frontier from deheterochromatinization to FDA-approved cristae repair.
Your body still has the blueprint for repair — peptides and pressurized oxygen are the missing construction crew.
Peptide therapy and hyperbaric oxygen work as architect and builder to unlock genomic repair mechanisms your body already possesses. From GHK-Cu's ability to reset 31.2% of human genes to MOTS-c's mitochondrial master switch, these tools move recovery science from symptom management to biological system optimization.
A D-retro-inverso peptide that selectively kills senescent cells by disrupting the FOXO4-p53 survival interaction, triggering mitochondrial apoptosis in aged 'zombie' cells while sparing healthy tissue.
FOXO4-DRI breaks the molecular shield that keeps senescent cells alive. By freeing p53 from FOXO4 sequestration, it triggers selective apoptosis in aged cells, restoring kidney function, testosterone levels, and tissue vitality in preclinical models.
A four-amino-acid peptide that activates telomerase, remodels chromatin, and restores melatonin synthesis from the pineal gland — addressing five hallmarks of aging simultaneously. The Russian clinical data spans 12–15 years. Independent Western replication barely exists.
Epitalon (AEDG) is a synthetic tetrapeptide modeled after the bovine pineal extract Epithalamin. It upregulates hTERT to activate telomerase, remodels heterochromatin to re-access silenced genes, restores endogenous melatonin production (160% increase in clinical trials), and demonstrated a 28% decrease in overall mortality over a 12-year human follow-up. A 2025 study revealed selective ALT pathway activation in cancer cells. The compound remains investigational — nearly all positive data originates from a single institutional network in St. Petersburg, and independent Western replication is virtually absent.
A 16-amino-acid mitochondrial messenger that mimics exercise at the cellular level — activating AMPK, reprogramming metabolism, and writing survival instructions directly into the nucleus. The science is striking. The stability problem is brutal.
MOTS-c is a mitochondrial-derived peptide (mitokine) that acts as an exercise mimetic through the Folate-AICAR-AMPK axis. It translocates to the nucleus under metabolic stress, enhances glucose uptake via GLUT4, promotes white-to-brown fat conversion, and reprograms immune cells toward anti-inflammatory phenotypes. A natural longevity variant (K14Q) exists in East Asian populations. Clinical translation is hampered by extreme instability (85–90% activity loss in 2–3 hours at room temperature) and a circulating half-life of only 1–2 hours.
A synthetic heptapeptide that acts as a molecular GPS for your body's repair crew — directing cell migration, building new blood vessels into injured tissue, and potentially re-activating embryonic healing pathways.
TB-500 is the synthetic analog of Thymosin Beta-4, a naturally occurring protein involved in actin regulation, cell migration, and tissue repair. Its unique mechanism targets the body's internal repair logistics rather than just providing raw materials.
A 15-amino-acid gastric pentadecapeptide that coordinates multi-system repair through angiogenesis, collagen synthesis, and gut-brain axis stabilization.
BPC-157 is a synthetic peptide derived from human gastric juice, notable for its extreme biochemical stability and capacity to coordinate tissue repair across musculoskeletal, vascular, and neurological systems.
The biochemical cofactors your body needs to support MOTS-c therapy.
Evidence-based supplement companion for MOTS-c — a 16-amino-acid mitochondrial messenger that mimics exercise at the cellular level — activating AMPK, reprogramming metabolism, and writing survival instructions directly into the nucleus. The science is striking. The stability problem is brutal.
35+
Articles
18
Categories